PHARMATECH NORWAY AS

0579 OSLO

Finances

Share Ownership

Return on Equity

28,38 %

Current Ratio

3,57

Debt-to-Equity Ratio

Key figures (NOK)	2022	2021	2020	2019
Revenue	2 291 000	1 542 000	922 000	612 000
Net Income	260 000	175 000	92 000	41 000
Total Assets	1 272 000	1 044 000	878 000	710 000
Total Equity	916 000	656 000	481 000	390 000

Income (NOK)	2022	2021	2020	2019
Revenue	2 291 000	1 542 000	922 000	612 000
Expenditure	1 957 000	1 320 000	803 000	563 000
Operating Profit	333 000	223 000	119 000	49 000
Financial Income	0	0	0	0
Financial Costs	1 000	0	0	0
Financial Balance	−1 000	0	0	0
Earnings Before Tax	333 000	223 000	119 000	49 000
Tax	73 000	48 000	27 000	8 000
Net Income	260 000	175 000	92 000	41 000

Balance (NOK)	2022	2021	2020	2019
Total Fixed Assets	1 000	6 000	14 000	21 000
Total Current Assets	1 271 000	1 038 000	864 000	688 000
Total Assets	1 272 000	1 044 000	878 000	710 000
Total Retained Equity	816 000	556 000	381 000	290 000
Total Equity	916 000	656 000	481 000	390 000
Total Long-Term Debt	0	174 000	174 000	176 000
Total Current Debt	356 000	214 000	222 000	144 000
Total Equity and Debt	1 272 000	1 044 000	878 000	710 000

Cash flow (NOK)	2022	2021	2020	2019
Sales Income	2 319 000	1 514 000	922 000	612 000
Other Income	−28 000	28 000	0	0
Revenue	2 291 000	1 542 000	922 000	612 000
Cost of Goods Sold	42 000	152 000	93 000	75 000
Salary Costs	467 000	175 000	152 000	59 000
Depreciation	5 000	8 000	8 000	8 000
Impairment	0	0	0	0
Expenditure	1 957 000	1 320 000	803 000	563 000
Operating Profit	333 000	223 000	119 000	49 000
Financial Income	0	0	0	0
Financial Costs	1 000	0	0	0
Financial Balance	−1 000	0	0	0
Dividends	0	0	0	0
Net Income	260 000	175 000	92 000	41 000

Balance details (NOK)	2022	2021	2020	2019
Goodwill	0	0	0	0
Total Intangible Assets	0	0	0	0
Real Eastate	0	0	0	0
Machinery and Plant Facilities	0	0	0	0
Fixtures	1 000	6 000	14 000	21 000
Total Tangible Assets	1 000	6 000	14 000	21 000
Total Fiancial Fixed Assets	0	0	0	0
Total Fixed Assets	1 000	6 000	14 000	21 000
Stock	652 000	406 000	380 000	254 000
Total Investments	0	0	0	0
Cash, Bank	364 000	558 000	440 000	300 000
Total Current Assets	1 271 000	1 038 000	864 000	688 000
Total Assets	1 272 000	1 044 000	878 000	710 000
Total Equity	916 000	656 000	481 000	390 000
Short-Term Group Debt	0	0	0	0
Total Long-Term Debt	0	174 000	174 000	176 000
Creditors	106 000	29 000	25 000	18 000
Unpaid Taxes	125 000	48 000	26 000	31 000
Dividends	0	0	0	0
Other Current Debt	50 000	90 000	142 000	90 000
Total Current Debt	356 000	214 000	222 000	144 000
Total Equity and Debt	1 272 000	1 044 000	878 000	710 000

Financial indicators	2022	2021	2020	2019
Return on Equity	28,38 %	26,68 %	19,13 %	10,51 %
Debt-to-Equity Ratio	0	0,27	0,36	0,45
Operating Profit Margin	14,54 %	14,46 %	12,91 %	8,01 %
Current Ratio	3,57	4,85	3,89	4,78
Quick Ratio	−4,29	−5,41	−5,47	−6,25
Equity Ratio	0,72	0,63	0,55	0,55
Gross Profit Margin	98,17 %	90,14 %	89,91 %	87,75 %